http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2261805-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff81a650b70e913d3b2524b45e4c7320
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-41
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-44
filingDate 1997-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2008-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68d109e5c050e648161877bf38e69525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_109e076ce721ddb8fb1bdf7f45ae5ff3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10df5e3eb893b8c0afbb6d99d7dd0a04
publicationDate 2008-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2261805-C
titleOfInvention Promotion of wound healing by chemically-modified tetracyclines
abstract A method for improving the healing response of epithelialized tissue (e.g., skin, mucosae) to acute traumatic injury is disclosed. The method includes employing a tetracycline compound, having substantially no antibacterial activity, to improve the capacity of the epithelialized tissue to heal acute wounds. Specifically, the method involves increasing the rate of collagen accumulation of the healing epithelialized tissue above that associated with wound healing in the individual. The method decreases proteolytic activity in the epithelialized tissue by means of the tetracycline compound, most commonly decreasing collagenolytic activity and/or decreasing gelatinolytic activity. Collagenase and gelatinase activity have been shown to be decreased by the method of the invention. Preferably, the method is employed to improve the wound healing capacity of human or animal subjects in whom such capacity is impaired. Also, the non-antibiotic tetracycline is preferably administered topically at the site of the wound.
priorityDate 1996-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP28300
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID173839
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33727
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP45845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507825
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB8A4W9
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675779
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP16636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675777
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05063
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407139333
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54689457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5509
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535986
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423512885
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB5DF27
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9Y4K0
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493982
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54679182
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID740516
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502692
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502717
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9Z175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423512671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54680690
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP58215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504097
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP28301
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4363005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428401249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406917592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583338
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1RD85
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71306420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454031468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424650142
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54684461
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP58022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426282998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424649925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3394

Total number of triples: 79.